J. Fiet et al., Development of a sensitive and specific new plasma 4-androstene-3,17-dionetime-resolved fluoroimmunoassay (TR-FIA), STEROIDS, 66(8), 2001, pp. 609-614
We describe, for the first time to our knowledge, the development of a new,
non-isotopic time resolved-fluoroimmunoassay of 4-androstene-3,17-dione in
plasma or serum. This steroid exhibits a key role in steroid metabolism an
d is often essayed in the investigation of various pathologic endocrine sta
tes. Most of the 4-androstene-3,17-dione immunoassays are performed using a
radioactive tracer. We synthesized a biotinylated 4-androstene-3,17-dione
tracer from 4-androstene-3,17-dione-3-carboxymethyloxime by acylation of bi
otinylaminopropylammonium trifluoroacetate. A specific rabbit anti 6-hemisu
ccinate-4-androstene-3,17-dione/BSA was indirectly bound via an anti-rabbit
sheep antibody immobilized on microtiter plate wells. The amount of biotin
ylated4-androstene-3,17-dione tracer was then measured by adding streptavid
in-europium, and the europium fluorescence was quantified by time resolved-
fluorescence (TR-FIA, Delfia System). The plasma 4-androstene-3,17-dione-le
vels measured with this non-isotopic assay were compared to those measured
with a radioimmunoassay previously published. In both cases, the same anti-
4-androstene-3,17-dione antibody was used, and the assays were performed af
ter an extraction step and a chromatographic step. The results obtained by
the two methods were virtually the same. However, the main advantages of th
e new plasma 4-androstenedione-3,17-dione time-resolved-fluorescence immuno
assay were its greater sensitivity than radioimmunoassay and its higher pre
cision. (C) 2001 Elsevier Science Inc. All rights reserved.